Leading global biopharmaceutical company CSL has partnered with APR.Intern to create new opportunities for postgraduate researchers to gain industry experience, strengthen collaboration between universities and industry, and foster the next generation of Australian biomedical researchers.
To be eligible, projects must be aligned with CSL’s nominated therapeutic areas: Hematology, Immunology, Immunoglobulins, Cardiovascular and/or Renal.
For more detailed information about the research areas supported through this partnership, view CSL’s therapeutic areas guide here (link to CSL research areas PDF)
Through this partnership, eligible Australian businesses can access a $15,000 subsidy towards a 3–6 month research internship for projects aligned with CSL’s nominated therapeutic areas.
With CSL’s contribution, businesses can access specialist research expertise from a PhD or Masters by Research student, with industry contributions starting from $4,900 + GST for a three-month internship.
| 3 months | 3 months | 3 months | 3 months |
|---|---|---|---|
| $4,900 + GST | $8,200 + GST | $11,500 + GST | $14,800 + GST |
CSL contributes $15,000 towards each eligible placement. Additional months are $3,300 per month. Funding is subject to project eligibility and approval.
Projects could address an existing research challenge, explore a new opportunity or progress an idea requiring specialist research expertise. Examples could include:
Projects using cross-cutting research methods and technologies may also be eligible where there is clear relevance to CSL’s therapeutic areas.
Read case studies from previous medical and biomedical interns here.
APR.Intern makes it easier for Australian businesses to access postgraduate research expertise through a structured and supported internship program.
With more than 10 years of experience facilitating industry–university research collaborations, APR.Intern offers:
Talk to APR.Intern. We can help explore your idea and assess alignment.